title: Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?
authors.affiliation: St. Paul's Hospital, University of British Columbia, Vancouver, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Ruedy
authors.forename: M
authors.initials: M
authors.lastname: Schechter
authors.forename: J S
authors.initials: JS
authors.lastname: Montaner
mesh_terms: D000386:AIDS-Related Complex / Q000517:prevention & control; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D015496:CD4-Positive T-Lymphocytes; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007958:Leukocyte Count; D011788:Quality of Life; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D015215:Zidovudine